Search Result "DPP4i"


Review Article

Role of DPP4 and DPP4i in Glucose Homeostasis and Cardiorenal Syndrome

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 23 Issue: 2 Year: 2023 Page: 179-187
Author(s): Siva Prasad Panda

Research Article

Impact of Sitagliptin on Non-diabetic Covid-19 Patients

Journal: Current Molecular Pharmacology
Volume: 15 Issue: 4 Year: 2022 Page: 683-692
Author(s): Gaber El-Saber Batiha,Naeem Qusty,Ali I. Al-Gareeb,Hayder M. Al-kuraishy

Short Communication

The Impact of COVID-19 Lockdown on Patients with Type 2 DiabetesMellitus: A Brief Report

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 23 Issue: 8 Year: 2023 Page: 1041-1045
Author(s):

Review Article

Pharmacological Management of Diabetes for Reducing Glucose Levels and Cardiovascular Disease Risk: What Evidence in South Asians?

Journal: Current Diabetes Reviews
Volume: 17 Issue: 9 Year: 2021 Page: 5-13
Author(s): Nazim Ghouri,Hareem Javed,Naveed Sattar

Review Article

Anti-Hyperglycemic Agents for the Treatment of Type 2 Diabetes Mellitus: Role in Cardioprotection During the Last Decade

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 17 Issue: 1 Year: 2017 Page: 19-31
Author(s): Duygu Kocyigit,Kadri Murat Gurses,Muhammed Ulvi Yalcin,Lale Tokgozoglu

Editorial free to download

Editorial: Do Some Glucagon-Like-Peptide-1 Receptor Agonists (GLP-1 RA) Reduce Macrovascular Complications of Type 2 Diabetes Mellitus? (A Commentary on the Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER) Trial)

Journal: Current Vascular Pharmacology
Volume: 14 Issue: 5 Year: 2016 Page: 469-473
Author(s): Vasilios G. Athyros, Niki Katsiki, Nikolaos Tentolouris

Review Article

Evolution of Guideline Recommendations on Insulin Therapy in Type 2Diabetes Mellitus Over the Last Two Decades: A Narrative Review

Journal: Current Diabetes Reviews
Volume: 19 Issue: 8 Year: 2023 Page: 84-94
Author(s): Sunil M. Jain

Alogliptin; A Review of a New Dipeptidyl Peptidase-4 (DPP-4) Inhibitor for the Treatment of Type 2 Diabetes Mellitus

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 14 Issue: 1 Year: 2014 Page: 64-70
Author(s): Sarmad Said,Azikiwe C. Nwosu,Debabrata Mukherjee,German T. Hernandez

Review Article

Dipeptidyl Peptidase-4 Inhibitor Induced Angioedema – An Overlooked Adverse Drug Reaction?

Journal: Current Diabetes Reviews
Volume: 14 Issue: 4 Year: 2018 Page: 327-333
Author(s): Susanne I. Scott,Michelle F. Andersen,Lise Aagaard,Christian Von Buchwald,Eva R. Rasmussen

Review Article

Endothelial Dysfunction and Platelet Hyperaggregation in Type 2 Diabetes Mellitus: The Era of Novel Anti-diabetic Agents

Journal: Current Medicinal Chemistry
Volume: 28 Issue: 20 Year: 2021 Page: 3935-3963
Author(s): Stylianos Daios,Georgia Kaiafa,Dimitrios Pilalas,Ifigeneia Nakou,Ilias Kanellos,Konstantinos Kirdas,Kalliopi Despoudi,Nikolaos Papanas,Christos Savopoulos

Previous   Next

Go To   Results 1 - 1 of 16

Apply Filters

Volume Years
Article Type
    Publication Title
    Subject Title

Content Type


Ads
© 2024 Bentham Science Publishers | Privacy Policy